Present optimal therapy in ovarian cancer
- 31 January 1986
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 22 (1) , 9-12
- https://doi.org/10.1016/0277-5379(86)90336-6
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMAThe Lancet, 1984
- Reversal of Adriamycin Resistance by Verapamil in Human Ovarian CancerScience, 1984
- Cis-platin based combination chemotherapy for advanced ovarian cancer. High overall response rate with curative potential only in women with small tumor burdensCancer, 1983
- JM8, SUCCESSOR TO CISPLATIN IN ADVANCED OVARIAN CARCINOMA?The Lancet, 1983
- The role of hexamethylmelamine in advanced ovarian carcinoma treatmentGynecologic Oncology, 1981
- A review of clinical experience with cis-platinum diammine dichloride : 1972–1978Biochimie, 1978
- Advanced Ovarian AdenocarcinomaNew England Journal of Medicine, 1978
- TREOSULFAN (DIHYDROXYBUSULPHAN) IN THE MANAGEMENT OF OVARIAN CARCINOMABJOG: An International Journal of Obstetrics and Gynaecology, 1977
- Chemotherapy of advanced ovarian carcinoma: A prospective randomized comparison of phenylalanine mustard and high dose cyclophosphamideGynecologic Oncology, 1974
- The chemotherapy of ovarian carcinomaCancer Treatment Reviews, 1974